95 related articles for article (PubMed ID: 15700924)
1. [Relationships between intravascular ultrasonographic findings and coronary risk factors in patients with normal coronary angiography].
Noike H; Hitsumoto T; Sakurai T; Sugiyama Y; Sato S; Iizuka T; Takahashi M; Shimizu K; Nakamura K; Ohsawa H
J Cardiol; 2005 Jan; 45(1):1-10. PubMed ID: 15700924
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.
deGoma EM; Leeper NJ; Heidenreich PA
J Am Coll Cardiol; 2008 Jan; 51(1):49-55. PubMed ID: 18174036
[TBL] [Abstract][Full Text] [Related]
3. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
[TBL] [Abstract][Full Text] [Related]
5. Comparison of coronary plaque composition among patients with acute coronary syndrome and stable coronary artery disease.
Li XM; Huang CX; Wang TS; Zhuang SW; Zhou H; Tian B
Chin Med J (Engl); 2008 Mar; 121(6):534-9. PubMed ID: 18364141
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
[TBL] [Abstract][Full Text] [Related]
7. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).
Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB
Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719
[TBL] [Abstract][Full Text] [Related]
8. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
[TBL] [Abstract][Full Text] [Related]
9. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
10. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM
Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648
[TBL] [Abstract][Full Text] [Related]
11. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
[TBL] [Abstract][Full Text] [Related]
12. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
Sachdeva A; Cannon CP; Deedwania PC; Labresh KA; Smith SC; Dai D; Hernandez A; Fonarow GC
Am Heart J; 2009 Jan; 157(1):111-117.e2. PubMed ID: 19081406
[TBL] [Abstract][Full Text] [Related]
13. A comparison of HDL and LDL cholesterol for prevalent coronary calcification.
Allison MA; Wright CM
Int J Cardiol; 2004 May; 95(1):55-60. PubMed ID: 15159039
[TBL] [Abstract][Full Text] [Related]
14. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].
Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E
Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711
[TBL] [Abstract][Full Text] [Related]
15. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
16. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH
Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708
[TBL] [Abstract][Full Text] [Related]
17. Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis.
Chhatriwalla AK; Nicholls SJ; Wang TH; Wolski K; Sipahi I; Crowe T; Schoenhagen P; Kapadia S; Tuzcu EM; Nissen SE
J Am Coll Cardiol; 2009 Mar; 53(13):1110-5. PubMed ID: 19324254
[TBL] [Abstract][Full Text] [Related]
18. Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction.
Farwell WR; Sesso HD; Buring JE; Gaziano JM
Am J Cardiol; 2005 Oct; 96(8):1129-34. PubMed ID: 16214451
[TBL] [Abstract][Full Text] [Related]
19. Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia.
Junyent M; Cofán M; Núñez I; Gilabert R; Zambón D; Ros E
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1107-13. PubMed ID: 16556855
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
